Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.

Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.

Item
http://www.wikidata.org/entity/Q39392579
ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment responseIcotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2.Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.A high-content assay strategy for the identification and profiling of ABCG2 modulators in live cells.Paclitaxel induces apoptosis and reduces proliferation by targeting epidermal growth factor receptor signaling pathway in oral cavity squamous cell carcinomaCytotoxicity of the Sesquiterpene Lactones Neoambrosin and Damsin from Ambrosia maritima Against Multidrug-Resistant Cancer CellsAlectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivoThe role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.Design of inhibitors of BCRP/ABCG2.MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner.Scaffold identification of a new class of potent and selective BCRP inhibitors.ABCG2/BCRP: Specific and Nonspecific Modulators.Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging.PharmGKB summary: very important pharmacogene information for ABCG2.Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response.Acryloylphenylcarboxamides: A New Class of Breast Cancer Resistance Protein (ABCG2) Modulators.
P2860

Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.

Item
http://www.wikidata.org/entity/Q39392579
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tyrosine kinase inhibitors inf ...... he PI3K/Akt signaling pathway.
@en
Tyrosine kinase inhibitors inf ...... he PI3K/Akt signaling pathway.
@nl
type
label
Tyrosine kinase inhibitors inf ...... he PI3K/Akt signaling pathway.
@en
Tyrosine kinase inhibitors inf ...... he PI3K/Akt signaling pathway.
@nl
prefLabel
Tyrosine kinase inhibitors inf ...... he PI3K/Akt signaling pathway.
@en
Tyrosine kinase inhibitors inf ...... he PI3K/Akt signaling pathway.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Tyrosine kinase inhibitors inf ...... he PI3K/Akt signaling pathway.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921